scispace - formally typeset
M

Milan Elleder

Researcher at Charles University in Prague

Publications -  151
Citations -  6225

Milan Elleder is an academic researcher from Charles University in Prague. The author has contributed to research in topics: Fabry disease & Neuronal ceroid lipofuscinosis. The author has an hindex of 35, co-authored 151 publications receiving 5776 citations. Previous affiliations of Milan Elleder include Czechoslovak Academy of Sciences & Academy of Sciences of the Czech Republic.

Papers
More filters
Journal ArticleDOI

New insights in cardiac structural changes in patients with Fabry's disease.

TL;DR: Echocardiographically detectable cardiac involvement is frequent with Fabry's disease, particularly in older subjects, and more pronounced in affected hemizygous men than in heterozygous women andValvular and especially LV structural changes may serve as a useful marker of disease severity.
Journal ArticleDOI

Mutations in DNAJC5, Encoding Cysteine-String Protein Alpha, Cause Autosomal-Dominant Adult-Onset Neuronal Ceroid Lipofuscinosis

TL;DR: This work identified in five individuals one of two disease-causing mutations, c.346_348delCTC and c.344T>G, in DNAJC5 encoding cysteine-string protein alpha (CSPα), which confirms a neuroprotective role for CSPα in humans and demonstrates the need for detailed investigation of CSP α in the neuronal ceroid lipofuscinoses and other neurodegenerative diseases presenting with neuronal protein aggregation.
Journal ArticleDOI

Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy.

TL;DR: Using proton magnetic resonance analysis on formaldehyde-fixed tissue the stored CTH was identified as globotriaosylceramide and was enzymatically degradable by control cell cultures but left uncleaved by mutant reference Fabry cells.
Journal ArticleDOI

The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations

TL;DR: The overall prevalence of LSDs in the Czech population is comparable to that reported for countries with well-established and advanced diagnostics, and a range of other LSDs have not been detected at all over the past three decades.